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1.56-fold compared with cells treated with H2O2 alone after 24-hour incubation
(P<0.01). Meanwhile, PAI-1 protein expression decreased in the 20mM Rb1-
pretreated cells by 1.39-fold compared to that in cells treated with H2O2 alone (P<0.01).
Conclusions: Our report demonstrates that Rb1 can exert protective effects on H2O2-
induced cellular injury through modulating PAI-1 expression.
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Dipeptidyl peptidase (DPP) -4 inhibitor exhibits anti-apoptosis effects in
isoproterenol-induced myocardial infarcted rats by inhibiting oxidative stress
Guo Bingyan, Li Yongjun
The Second Hospital of Hebei Medical University
Objectives: Cardiac apoptosis plays an important role in the pathology of myocar-
dial infarction. The protective effects of Dipeptidyl peptidase (DPP) -4 inhibitor
(vildagliptin) on cardiac apoptosis were evaluated in isoproterenol induced myocardial
infarcted rats.
Methods: Male Wistar rats are treated intravenously with Vildagliptin (2 mg/kg/day)
daily for a period of 21 days. After 21 days of pretreatment, isoproterenol (100 mg/kg)
was injected subcutaneously to rats at an interval of 24 h for 2 days (on 22th and 23th
day) to induce myocardial infarction. Cardiac diagnostic markers, heart lipid peroxi-
dation, antioxidant system, histopathological changes of the heart and apoptosis were
evaluated in isoproterenol induced myocardial infarcted rats.
Results: Isoproterenol induced myocardial infarcted rats showed a signiﬁcant increase
in the levels of serum cardiac diagnostic markers, heart lipid peroxidation products and a
signiﬁcant decrease in the activities/levels of heart antioxidants, compared with normal
rats. Additionally, Histopathological ﬁndings of myocardial infarcted rats revealed
marked necrosis. Real Time Polymerase Chain Reaction study revealed an increase in
the myocardial expression of Bax, caspase-8, caspase-9 and Fas genes and a decrease in
the myocardial expression of Bcl-2 and Bcl-xL genes.Vildagliptin (2 mg/kg/day) pre-
treatment decreased the levels of serum cardiac marker enzymes, reduced heart lipid
peroxidation and minimized the alterations the activities/levels of heart antioxidants of
isoproterenol-induced myocardial infarcted rats. Histopathological study evidenced that
the pretreatment with Vildagliptin inhibited myocardial damage. Vildagliptin pre-
treatment also showed protective effects on apoptosis. The in vitro study also revealed
the free radical scavenging and anti-apoptosis activity of Vildagliptin.
Conclusions: Thus, Vildagliptin protected the myocardial infarcted rat’s heart against
apoptosis by inhibiting oxidative stress.
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Effect of metoprolol on expression and vasodilatation function of AT2R in SHR
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Objectives: The interactional relationship between the sympathetic nervous systems
(SNS) and the renin-angiotensin-aldosterone system (RAS) has been revealed but
poorly investigated. The present work was designed to explore the effect of meto-
prolol (MET) treatment on the RAS, especially the expression and vasomotor function
of AT2R, in spontaneously hypertensive rats (SHR).
Methods: SHR was treated with metoprolol for 4 weeks. The dynamic changes of the
blood pressure, renin activity, Ang II concentration and AT2R expression were
investigated. Superior mesenteric resistance arteries were isolated for determining the
protein expression of AT1R and AT2R. Perfusion experiment was carried out to
explore the vasomotor function of AT2R.
Results: The results showed that up-regulated renin activity and Ang II concentration
of plasma in SHR were inhibited by metoprolol treatment. In isolated superior
mesenteric arteries from both WKY and SHR, Ang II perfusion induced vasodilatation
after AT1R inhibition by telmisartan, although the vasodilatation was harmed in SHR.
Furthermore, AT2R inhibitor PD123319 arrested the vasodilatation induced by Ang
II. SHR received metoprolol exerted improved vasodilatation mediated by AT2R
(47.295.16% versus 24.994.93% for MET and SHR, respectively, P<0.05).
Western blot analysis showed that metoprolol restored expression of AT2R in SHR,
which may contribute to metoprolol’s antihypertensive effect.
Conclusions: These results suggested an impact of b-adrenergic blocker on RAS and
supported an important role of AT2R in antihypertensive treatment.
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Action and Mechanism of Secreted Frizzled-Related Protein 5 in Cardiomyocyte
Hypertrophy
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Objectives: Secreted frizzled-related protein 5 (Sfrp5) has been described as novel
adipokine with anti-inﬂammatory properties at present. However, it’s expression and
protection mechanisms in the cardiomyocyte hypertrophy at the cellular level are not
thoroughly understood. Here, the authors report for the ﬁrst time by means of
angiotensin II induced cardiomyocyte hypertrophy in vitro that the expression and
mechanisms of Sfrp5.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BMethods: Cardiomyocytes were preincubated with Ang II through primary culture of
cardiac cells of neonatal SD rats. Telmisartan and PD123319 were used to block Ang
II type-1 and type-1 receptors respectively. Rho proteins have been suggested as major
contributors to cardiac hypertrophy. Here, inhibition of the Rho/ROCK pathway by
Y-27632, a selective inhibitor of ROCK, we determined the hypothesis that Rho and
Rho-associated kinase (Rho/ROCK) as mediators of the expression of sFRP5 in
angiotensin II (Ang II) -induced cardiomyocyte hypertrophy. Reverse transcription-
polymerase chain reaction and Western blot were used to estimate the expression of
sfRP5, brain natriuretic peptide (BNP) and phosphorylation of MYPT-1.
Results: sFRP5 was discovered expressed in cardiomyocytes. Ang II treatment
induced the increased expression of sFRP5 and BNP in a dose-and time-dependent
manner in cardiomyocytes, after preincubating with AT1-R antagonist telmisartan
completely blocked Ang II-induced sFRP5 expression increasement. The recession of
phosphorylation of MYPT-1 (P-MYPT 1) and sFRP5 were expressed after inhibiting
of Rho/ROCK.
Conclusions: The increased sFRP5 expression was mainly through the AT1-R-Rho/
ROCK signal pathway in the process of Ang IIinduced cardiomyocyte hypertrophy.
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The research on antihypertensive effect of metoprolol inﬂuenced by knockdown
of b1-AR in myocardial tissue of Spontaneously Hypertensive Rats
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Objectives: To investigate the effect of knockdown of b1-AR in myocardium on
metoprolol antihypertension of SHRs.
Methods: (1) Construct pAAV-ZsGreen-ADRB1-shRNA plasmid; pAAV-ZsGreen-
ADRB1-shRNA plasmid was constructed according to shRNA principle and b1-AR
coding sequence in Genebank. Conﬁrmed by enzyme digestion and gene sequencing,
showing that 100% identical to its accession number. The plasmid was then packaged
to recombinant adeno-associated virus named AAV9- shRNA-ADRB1-ZsGreen and
harvested (viral titer was 1.5x1012vg/ml). (2) Spontaneousely Hypertensive Rats
treatments; 36 SHRs were grouped into six randomly as follows:Group 1, AAV9-
shRNA-ADRB1-ZsGreen + metoprolol (n¼6); Group2, AAV9-shRNA-ADRB1-
ZsGreen+saline (n¼6); Group 3, AAV9-CMV-ADRB1- ZsGreen + metoprolol
(n¼6); Group 4, AAV9-CMV-ADRB1-ZsGreen + saline Group (n¼6); Group 5,
sham + metoprolol Group (n¼6); Group 6, sham + saline (n¼6). Metoprolol were
given by gavage in 50mg/kg/d dose. All of them were monitored their blood pressure
weekly. Rats were killed and dissected the myocardial tissue after 4 weeks. (3) The
research on the expression of b1-AR in myocardial tissue among all rats groups in
transcription and translation levels, Real-time RT-PCR, Immunohistochemistry and
Western blot were used to assay the expression of b1-AR gene.
Results: (1) Comparison of the b1-AR expression among each group: Real-time
RT-PCR results showed that AAV9-shRNA-ADRB1-ZsGreen injection could
signiﬁcantly decrease b1-AR mRNA expression compared with the negative control
group (P <0.05) Immunohistochemistry results showed that it could signiﬁcantly
decrease theb1-AR protein expression compared with the negative control and sham
group (P <0.05 ), Western blot results showed that it also could signiﬁcantly decrease
the b1-AR protein expression compared with the negative control group (P <0.05).
(2) Comparison of the antihypertensive effects among each group: After 4 weeks of
the intervention, systolic blood pressure in group 1, group 2, group 3, group 5 was
signiﬁcantly lower than group 4 and group 6 (P<0.05); After 4 weeks of metoprolol
intervention, the SBP drop pressure amplitude of AAV9-shRNA-ADRB1-ZsGreen
injection group were signiﬁcantly lower than the negative control group and the sham
group (22.841.72 vs.28.782.72 vs.30.165.71, P<0.05).
Conclusions: (1) The AAV9-shRNA-ADRB1-ZsGreen is successfully constructed
and it can signiﬁcantly reduce the b1-AR expression in myocardial of SHRs. (2)
Knockdown of b1-AR in myocardial tissue of Spontaneousely Hypertensive Rats
resulted in worse antihypertensive response to metoprolol; it may be one of the rea-
sons for inﬂuencing individual antihypertensive response to metoprolol.
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Objective: The fundamental researches of cardiovascular disease veriﬁed that inter-
calated disc-related gene ZO-1varis in different myocardial pathologic conditions, and
it interacts with Cx43. This research is about to construct recombinant lentivirus
over-expressing vector of porcine ZO-1 gene, to infect iPS cells, to obtain iPS cells
carrying this target gene.
Methods: The ZO-1gene sequence publicated on Gendbank was analyzed, and
designed a couple of primer containing both BamHI and SalI. The porcine ZO-1 gene
was ampliﬁed by PCR, and cloned into lentiviral expression vector, to construct the
recombinant Lenti-EF1a-EGFP-TRE-ZO1 vector; the vector was conﬁrmed by DNA
sequencing. The production of lentivirus was obtained by using pVSVG, delta
8.91and fugene to contransfect 293T cells. The titer of lentivirus was testd with
ﬂuorescent expression, to infect iPS cells.asic and Translational Medicine C43
Results: The recombinant lentivirus plasmid carrying ZO-1 was correctly constructed,
it was identiﬁed correct by double enzyme digestion and DNA sequencing. The
lentiviral packaging was succeed, and the titer of lentivirus was 1.42108IU/ml.
Conclusion: Lenti-EF1a-EGFP-TRE-ZO1 lentiviral vector has been successfully
constructed. The titer of lentivirus was 1.42108IU/ml, it was used to infect iPS cells,
which will be useful for further study in vivo, to understand its function and its unique
effects under different pathological status of heart, and open new doors for the
treatment of cardiovascular diseases.
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Exogenous Hydrogen Sulﬁde Delays Nicotinamide-Induced Premature
Senescence via SIRT1 pathway in Human Umbilical Vein Endothelial Cells
Qiao Weili, Zheng Meihua, Liu Lei, Yan Changdong
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Objectives: The present study was designed to observe the effect of hydrogen sulﬁde
(H2S) on cellular senescence of human umbilical vascular endothelial cells (HUVECs
CC-2517) and its underlying mechanism.
Methods: The premature senescence-like phenotypeHUVECs (the fourth passage) was
induced by nicotinamide (NAM, an inhibitor of SIRT1) at the concentration of 5mmol/L
for 12 hours. Cells were cultured with sodium hydrosulﬁde (NaHS, 12.5, 25, 50,
100mmol/L) added into the fresh medium for 48 hours on the basis of premature
senescence-like phenotyoe HUVECs. The fourth passage of HUVECs was considered
as young group. Senescence associated (SA) -b-galactosidase activities were detected to
evaluate cell senescence, and the expression of senescence associated heterochromatin
foci (SAHF) was visualized by DAPI DNA staining. The mRNA and protein levels of
SIRT1 were detected using RT-PCR and western blotting analysis, respectively.
Results: The results showed that b-galactosidase positive cells and the formation of
SAHF were markedly increased after treatment with NAM (5mmol/L) for 12h. We also
found that NaHS (12.5mmol/L) had no effect on the percentage of SA b-gal positive cells
and the expression of SAHF, and the hallmarks decreased at the concentration of 25 and
50mmol/L, reaching the minimum at 50 mmol/L, while the percentage of SA b-gal
positive cells and the expression of SAHF increased at the concentration of 100mmol/L.
Furthermore we found that SIRT1 expression both on protein and mRNA in the
Y+N+S50 group was signiﬁcantly increased compared with that in Y+N group.
Conclusions: NaHS delays senescence of HUVECs induced by NAM via up-regu-
lation of SIRT1 expression.
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Objectives: Cardiac channelopathies are primary arrhythmias caused by variations in
the genes encoding cardiac ion channels. It is one of the major causes which could
lead to sudden cardiac death.
Methods: The pathological change leading to cardiac channelopathies is intimately
linked to the geno-variations. MicroRNAs (miRNAs) are one of the participants that
regulate the target gene expression.
Results: Burgeoning evidences indicated that miRNAs are closely associated with
myocardial development, proliferation, differentiation, apoptosis and ion channel
remodeling, especially involved in arrhythmias, congenital heart disease, hyperten-
sion, and myocardial ischemia. In vivo and in vitro studies suggested that miRNAs
may serve as a diagnostic biomarker for cardiac channelopathies. They can modulate
the function of cardiac ion channel genes and would be a good choice to act as a
miRNA-based therapy method.
Conclusions:We review the mechanisms and functions of miRNAs related to cardiac
ion channels and focus on the potential perspective of miRNAs as a novel therapeutic
target for cardiac channelopathies.
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ZP2495 improves cardiomyocyte energy metabolism post myocardial
ischemia-reperfusion injury in db/db diabetic mice
Li Shuang1, Dongdong Sun1, Feng Cao2
1Department of Cardiology, Xijing Hospital, Fourth Military Medical University,
Xian, Shanxi, China, 2Department of Cardiology, Chinese People’s Liberation Army
General Hospital, Beijing, China
Objectives: This study was designed to evaluate the impact of a glucagon-GLP-1
dual-agonist (ZP2495) on cardiac function and energy metabolism after myocardial
ischemia-reperfusion injury in db/db mice, and the underlying mechanisms involved.
Methods: The peptides of glucagon, GLP-1 receptor agonist (ZP131) and glucagon-
GLP-1 dual-agonist (ZP2495) were synthesized and puriﬁed by ChinaPeptides. Wild-
type (WT) and db/db mice received 4-weeks treatment of glucagon, ZP131 or ZP2495
followed by left anterior descending coronary artery (LAD) ligation and reperfusion.
Cardiac function, hemodynamic parameters, glucose metabolism, myocardial infarct
size, cardiomyocyte apoptosis, mitochondrial ultrastructural morphology, mitochon-
drial respiration and ATP synthesis were measured. Mitochondrial membraneC44 JACC Vol 64/16/Suppl C j Octobpotential, mitochondrial cytochrome c release and mitochondria reactive oxygen
species (ROS) generation were assessed in high-glucose-induced neonatal rat ven-
tricular myocytes (NRVMs) after simulated ischemia/reperfusion (SI/R) injury. The
expressions of FoxO3a, phospho-FoxO3a (Thr32, Ser413), Akt, phospho-Akt
(Ser473, Thr308) AMPK, phospho-AMPK (Thr172), Bim, Bax, Bcl-2, Bad, phospho-
Bad, MnSOD, Catalase,Sirt1, PGC1a, Acetylated-Lysine, Nrf-1, Tfam of the heart
tissue were detected by Western blot.
Results: ZP2495 treatment improved cardiac function and cardiac glucose metabolism,
decreased apoptotic cardiomyocytes, improvedmitochondrial ultrastructural morphology
and mitochondrial energetic transition of db/db mice after cardiac I/R injury. ZP2495
treatment preventedmitochondrial depolarization and reduced the release of cytochrome c
and mitochondria reactive oxygen species (ROS) generation in high-glucose-induced
NRVMs after SI/R injury. Western blot revealed that ZP2495 exerted anti-apoptotic
and anti-oxidation effect on cardiomyocyte of db/db mice after cardiac I/R injury via
Akt/FoxO3a-dependent mechanism. In addition, ZP2495 improved energy metabolism
and increased mitochondrial biogenesis in hearts of db/db mice subjected to I/R injury
through AMPK/FoxO3a and AMPK-SIRT1-PGC-1a pathway.
Conclusions: Glucagon and GLP-1 dual-agonist (ZP2495) protects against myocar-
dial I/R injury in db/db mice, which may contribute to the improvement of cardiac
function and cardiac energy metabolism. The protective effects of ZP2495 may be
associated with the Akt/FoxO3a, AMPK/FoxO3a and AMPK-SIRT1-PGC-1a path-
ways activation.
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Statin attenuate cardiac hypertrophy by regulating autophagy via AKT/mTOR
Pathway in Spontaneously Hypertensive Rats
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Objectives: Autophagy is activated in hypertension-induced cardiac hypertrophy, in
which the mechanisms are not clear. Our previous study has demonstrated that ator-
vastatin inhibites heart remodeling spontaneously hypertensive rats (SHR). This study
was designed to determine the regulation of atorvastatin on cardiac autophagy in
SHRs.
Methods: Twenty-four male SHRs at 8 weeks of age were randomly divided into four
groups receiving vehicle (SHR+V) or atorstatin at a dose of 50 mg/kg/day
(SHR+ATO) until ages of 6 months or 12 months old. WKY rats were used as
controls. Cardiac magnetic resonance (CMR) was used to evaluate heart functions.
Autophagy was demonstrated by the up-regulated expression of microtubule-associ-
ated protein-1 light chain 3-II (LC3-II), Beclin-1, caspase-3, the formation of auto-
phagosomes, and by the electron microscopic ﬁndings. Western blot analysis shows
the expression of the proteins.
Results: Atorstatin treatments for both 4 and 10 months signiﬁcantly attenuated car-
diac dysfunction, remodeling, and atrial natriuretic peptide expression in SHRs, which
were increased compared with WKY rats. At 12 months of age, autophagy was found
to be activated in the heart of SHRs treated with vehicle or atorstatin. The activated
autophagy was especially increased in the cardiomyocytes of SHRs with atorstatin
treatment for 10 months. P-Akt and P-mTor decreased in the heart of SHR versusWKY
rats, while atorstatin further decreased cardiac akt and mTor phosphorylation.
Conclusions: These ﬁndings suggest that atorvastatin attenuated cardiac remodeling
and heart dysfunction in SHR probably through its regulation on cardiac autophagy
via akt/mTor pathways.
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Effects of EPC-derived Microvesicles on Ang II-induced Cardiomyocyte
Hypertrophy and Apoptosis
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Objectives: Cell-released microvesicles (MVs) are implicated in mediating cell-to-cell
communication and are able to modulate target cell functions. Previous evidence in-
dicates that endothelial progenitor cells (EPCs) -derived MVs can modulate endo-
thelial cell survival and proliferation. In this study, we evaluated whether EPC-MVs
could protect cardiomyocytes (CMs) against angiotensin II (Ang II) -induced hyper-
trophy and apoptosis.
Methods: The cell line H9c2 CMs were exposed to Ang II in the presence or absence
of EPC-MVs. Cell viability, apoptosis, surface area and b-myosin heavy chain
(b-MHC) expression were analyzed. To investigate the underlying mechanisms,
reactive oxygen species (ROS) generation, serine/threonine kinase (Akt), phospho-Akt
(P-Akt), endothelial nitric oxide synthase (eNOS) and phospho-eNOS (P-eNOS)
expression levels were measured. The inhibitors of phosphatidylinositol-3-kinase
(PI3K) and NOS were used for pathway veriﬁcation. The role of MV carried RNAs in
mediating these effects was also explored.
Results: Results showed: (1) EPC-MVs were able to protect CM against Ang II-in-
duced changes in cell viability, apoptosis, surface area and b-MHC expression;er 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
